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Key messages
What is already known about this subject?
 ► the rheumatoid arthritis (ra) Mri score (raMriS) 
has been developed and validated for scoring Mri 
of the metacarpophalangeal-joints and wrists for re-
search purposes.
 ► the validation of the raMriS applied to the forefeet 
is unknown.
What does this study add?
 ► current evidence on the raMriS applied to the fore-
feet was insufficient according to the Outcomes in 
rheumatology clinical trials criteria.
How might this impact on clinical practice?
 ► a research agenda was determined.
AbstrAct
Objective Mri depicts inflammation and structural 
damage in rheumatoid arthritis (ra). the validity of 
Mri-scoring of wrist-joints and metacarpophalangeal-
joints according to the ra Mri score(raMriS) has been 
demonstrated. the Outcomes in rheumatology clinical 
trials (OMeract) raMriS Working group recently called 
for validation of the raMriS of the metatarsophalangeal 
(MtP)-joints. therefore, a systematic literature review was 
performed to test if the raMriS applied to the MtP-joints 
meets the OMeract Filter of truth, Discrimination and 
Feasibility.
Methods Medical literature databases up to January 
2018 were systematically reviewed for studies reporting 
on raMriS applied to Mri of the MtP-joints in ra. to be 
included, an article had to contain at least one Mri-feature 
(synovitis, bone marrow oedema (BMe), tenosynovitis, 
erosion, joint space narrowing (JSn)) and one item from 
the OMeract Filter: truth (face, content and construct 
validity), Discrimination (test-retest reliability, ability to 
discriminate in trials, longitudinal construct validity and 
thresholds of meaning) and Feasibility.
Results Of the 749 retrieved studies, 13 were included, 
of which 9 provided data on construct validity, 4 on 
discrimination (3 on reliability, 2 on longitudinal construct 
validity and 1 on ability to discriminate in trials) and none 
on feasibility. construct validity was suggested for BMe 
and erosions, but lacking for synovitis, tenosynovitis and 
JSn. Data for discrimination remain to be developed for all 
outcomes.
Conclusion according to the OMeract Filter, the validity 
of the raMriS of the forefeet is insufficient in different 
aspects. a research agenda was determined.
InTROduCTIOn
In rheumatoid arthritis (RA), conventional 
radiographs are traditionally used to assess 
structural damage as an outcome measure for 
the efficacy of treatment in trials. However, 
radiographs do not assess disease activity, and 
with improving treatment strategies, struc-
tural damage has become less common.1 
Therefore, in recent years MRI is increas-
ingly used in studies, as it detects damage 
with greater sensitivity than radiography and 
in addition provides information about joint 
inflammation.
As part of The Outcomes in Rheumatology 
Clinical Trials (OMERACT), an RA MRI 
Working Group was set up that developed an 
RA MRI scoring system (RAMRIS) to stan-
dardise MRI-scoring for research-purposes.2 
This working group prioritised the wrist and 
metacarpophalangeal-(MCP)-joints due to 
their frequent involvement in RA and the 
large amount of MRI data on these joints.2 
However, studies in early RA have revealed 
MRI findings to be as prevalent in the meta-
tarsophalangeal-(MTP)-joints as in the MCPs 
and wrists.3–5 In addition, radiographic studies 
have shown that erosive change occurs more 
commonly in the feet than in the hands and 
also earlier.6–8 The RAMRIS has not been 
described for the MTPs by the working group. 
There seems to be a paradox between the 
notion that the feet are commonly affected in 
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RA, and the priority given to MRI studies of hands over 
feet. The MRI in arthritis working group has recognised 
this, as their recently published updated recommenda-
tions call for validation of the existing RAMRIS in other 
joints than the hands, such as the MTPs.9
The OMERACT-group has developed a Filter that 
provides guidelines for the development and validation 
of outcome measures for use in clinical trials.10–12 This 
systematic literature review set out to assess whether 
the existing RAMRIS, when applied to the MTP-joints 
in patients with RA, meets the OMERACT Filter 2.1 of 
Truth, Discrimination and Feasibility. More specifically, 
it was aimed to answer the question if there is currently 
enough evidence to conclude that applying the RAMRIS 
to MRI-scoring of the MTP-joints is a valid outcome 
measure in the assessment of joint inflammation and 
structural damage in RA, and subsequently to identify a 
research agenda for OMERACT criteria that still require 
studying for the MTP-joints.
MeTHOds
Identification of studies
In cooperation with a medical librarian (JWS), a system-
atic literature search was performed to obtain all manu-
scripts reporting on studies that perform MRI of the 
MTP-joints in patients with RA. Medical literature data-
bases (PubMed, Embase, Web of Science, COCHRANE, 
Emcare, Academic Search Premier and ScienceDirect) 
were searched up to January 2018, using all variations 
of the following key words: ‘foot’, ‘rheumatoid arthritis’ 
and ‘MRI’ (see online supplementary file 1 for the exact 
search strings). Animal studies, reviews, abstracts and 
letters to the editor and in languages other than English 
were excluded from the search.
Inclusion criteria
All retrieved titles were screened, if deemed relevant 
abstracts were reviewed and finally full text articles were 
read by one reviewer (YJD). A random sample of 75 titles 
(10% of the titles identified by the literature search) was 
also reviewed by a second reviewer (AHM), resulting in 
a similar selection of titles. Therefore, further extraction 
was done by a single reviewer. In case of uncertainties in 
the reviewing process by the single reviewer, these were 
discussed and solved by consensus with AHM. Retrieved 
studies that reported on diseases other than RA, that 
were not scored according to the RAMRIS applied to the 
foot or that did not analyse data of the MTP-joints sepa-
rately were excluded.
Studies reporting on the RAMRIS-measures in the 
MTP-joints in patients with RA were evaluated and catego-
rised according to the following OMERACT Filter items: 
Truth (subdivided into face, content and construct), 
Discrimination (subdivided into test-retest reliability, 
ability to discriminate in randomised controlled trials 
(RCTs)/comparative studies, longitudinal construct 
validity and thresholds of meaning) and Feasibility, of 
which a detailed description is provided elsewhere.10 11 
Face and content validity of the Truth aspect were not part 
of the systematic literature search, as they are considered 
subjective measures and in the past have been assessed 
by consensus.11 Hence, the assumption was made that 
MRI captures the intended pathophysiological feature 
for synovitis, bone marrow oedema (BME), erosions and 
joint space narrowing (JSN). For face and content validity 
of tenosynovitis on the other hand, anatomic atlases were 
explored to study whether the tendons have a sheath, 
and thus whether MRI is able to capture this intended 
pathophysiological feature. Per OMERACT-item a PICO 
(participants, interventions, comparisons, outcomes) was 
made, this resulted in the following inclusion criteria per 
OMERACT-item:
 ► Construct validity was evaluated in studies comparing 
one or more RAMRIS-features to conventional radi-
ography, ultrasound, CT, histology, physical exam-
ination and symptoms. Both cross-sectional and 
longitudinal studies were included.
 ► Test-retest reliability was evaluated in studies 
comparing one or more RAMRIS-features in the same 
patients, either by the same performer over time 
or by different performers at the same time point. 
Both cross-sectional and longitudinal studies were 
included.
 ► Ability to discriminate in RCTs/comparative studies 
(sensitivity to change) was evaluated in studies that 
measured change of one or more RAMRIS-features 
over time, either in RCTs if available or from non-ran-
domised studies or cohorts.
 ► Longitudinal construct validity (responsiveness) was 
evaluated in studies that measured change in one 
or more RAMRIS-features compared with change 
in other instruments like conventional radiography, 
ultrasound, CT, histology, physical examination and 
symptoms. This differs from ‘Construct validity’ by 
the fact that it includes MRI at different time points 
rather than at one point in time.
 ► Thresholds of meaning was evaluated in studies that 
rate patients with a certain response to therapy (eg, 
minimum important difference or patient acceptable 
symptom state) as measured by a change in one or 
more RAMRIS-features.
 ► Feasibility was evaluated in studies describing the cost, 
patient and responder burden, equipment needs, 
sensitivity of content and overall ease of use of one 
or more RAMRIS-features. Both cross-sectional and 
longitudinal studies were included.
Studies that fulfilled the requirements for at least one 
of these items were included in this review.
After screening and including, next the articles were 
weighted by two reviewers (YJD and AHM) according to 
predefined criteria. First, to select MRI-data with high 
quality, the MRI had to be performed on ≥1.5 Tesla (T) 
MRI and to use gadolinium contrast-enhancement (CE) 
for synovitis and tenosynovitis. Second, the results were 
further weighted by the presence of replication studies. 
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Figure 1 Overview of literature research.
For the final conclusion, the validity of an OMERACT 
criterion was considered to be suggested if there were ≥2 
studies with high-quality MRI-data of which ≥2/3rd had a 
uniform conclusion (meaning that the associations found 
in the studies point in the same direction of either a posi-
tive or a negative/absence of any association), this type of 
validity was categorised as ‘++’ or – –’ depending on the 
directionality of the effect. If only one article was avail-
able with regard to the type of validity, then according 
to the direction of the association, it was categorised as 
‘+’ or ‘–’, and the conclusion was drawn that limited data 
possibly suggested the validity to be present but more 
studies were needed for a more definite conclusion. If 
the high-quality MRI-articles were not uniform in their 
conclusion, or if articles were available but the MRI-data 
was not deemed to be of high quality, then it was cate-
gorised as ‘+/-,’ meaning data were available but insuffi-
cient for a conclusion. If there were no articles available 
at all, then it was categorised as ‘?’, meaning that there 
were no data available.
The MRI-features studied were synovitis, BME and 
tenosynovitis as measures of inflammation, and erosions 
and JSN as measures of structural damage. An updated 
RAMRIS has recently been published that now besides 
synovitis, BME and erosions also includes tenosynovitis 
and JSN.9 Considering the short time interval between 
this systematic literature search and the publication of 
this updated RAMRIS definition, the systematic search 
included the updated RAMRIS and the old RAMRIS-defi-
nition for synovitis, BME and erosions, for tenosynovitis 
the score according to Haavardsholm et al and for JSN 
the score that was proposed by Ostergaard.2 13 14
statistical analyses
Due to the heterogeneity of the studies and the differ-
ence in outcome measures that were used, it was not 
possible to perform a meta-analysis. Therefore, we chose 
to perform a descriptive review.
ResulTs
literature flow
After removing duplicate references, 749 unique refer-
ences were identified (figure 1). After reviewing 115 
abstracts and 41 full-text articles, 13 articles were included 
in the review. Of the included studies, nine fulfilled the 
inclusion criteria for evaluation of the construct aspect 
of Truth,15–23 four on Discrimination (of which three on 
test-retest reliability,5 24 25 two on longitudinal construct 
validity5 25 and one on the ability to discriminate26) and 
none for Feasibility.
study characteristics
The 13 included studies are depicted in tables 1–3, 
grouped according to the category of the OMERACT 
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Filter that is addressed: table 1 addresses articles on 
construct (aspect of Truth), table 2 on test-retest relia-
bility (aspect of Discrimination) and table 3 on longitu-
dinal construct validity and clinical trial discrimination 
(also aspects of Discrimination). These tables also depict 
the studies that fulfilled the inclusion criteria but were 
considered to have lower MRI-quality as described in the 
methods and thus were not part of the final conclusions 
drawn. Overall, the studies included a small number of 
patients, with a median number of 39. There were no 
RCTs, nine studies were cross-sectional and four longitu-
dinal. MRI was most often performed on a 1.5 T scanner 
(n=7).
The OMERACT Filter was applied to each MRI-mea-
sure separately. These results will be discussed per 
MRI-feature and are summarised in table 4.
synovitis
The RAMRIS defines MRI-detected synovitis as an area 
in the synovial compartment that shows above-normal 
postgadolinium enhancement of a thickness greater 
than the width of the normal synovium.2 As specified in 
the methods, face and content validity for MRI-detected 
synovitis were considered to be evident (‘++’ in table 4).
Regarding construct validity, three studies were 
deemed to have MRI-data of high quality.16 20 22 Syno-
vitis was associated with plantar plate pathology, which 
represents a failure of the ligamentous system and 
displacement of the plantar plates of the forefoot leading 
to malformation.22 When patients were followed for 
up to 24 months, MRI-detected synovitis was not asso-
ciated with radiographic damage.20 Correlations were 
found between MRI-detected synovitis in MTP-1 and a 
decrease in movement of the same joint.16 Although this 
is a positive correlation, the outcome of decreased range 
of motion in MTP-1 is not typical for RA, but is affected 
in for instance osteoarthritis. Therefore, this study was 
not considered in the final conclusion. Overall, one out 
of two studies found a positive association, therefore no 
uniform conclusion can be drawn on construct validity 
for MRI-detected synovitis (‘+/-’ in table 4).
Test-retest reliability has been confirmed in one study 
that has shown excellent inter-reader and intrareader 
reliability for scoring synovitis (‘+’).24 For longitudinal 
construct validity and the ability to discriminate in trials, 
the two studies available did not meet the quality criteria 
for MRI (‘+/-’).5 26 There were no data regarding thresh-
olds of meaning or feasibility (‘?’).
Bone marrow oedema
Also referred to as osteitis, BME is defined as a lesion 
within the trabecular bone, with ill-defined margins and 
signal characteristics consistent with increased water 
content.2 Again, face and content validity were deemed 
present (‘++’).
Construct validity was examined in six studies that met 
the quality criteria for the MRI-protocol.15 18–22 MRI-de-
tected BME was associated with clinical swelling, with pain 
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Table 2 Summary of previous studies on ‘discrimination’: test-retest reliability
Reference N Population MRI CE Reading 
Reliability per MRI-feature
Conclusion SYN BME TS ERO JSN Foot
Baan et al, 
201524
29 RA 1.5 T + Inter
Intra
0.94
0.85
0.77
0.70
– 0.95
0.89
– – Good to excellent 
interobserver and 
intraobserver reliability 
according to the 
RAMRIS method.
Ejbjerg et al, 
200525
35 RA 0.2 T ? SDD – – – 1.36 – – SDD for erosions in 
MTPs was low at 1.36, 
for MCPs 1.24 and 
wrist 2.13.
Sewerin et al, 
20145
26 Early RA 0.2 T + SDD 1.29 0.87 – 0.87 – 1.81 Inter-reader SDDs at 
baseline were good as 
presented for the foot 
for all inflammation 
summed and for MTP-
2 for all subtypes of 
inflammation separate. 
In comparison SDD 
of MCPs and wrist 
were 2.23 and 4.10, 
respectively.
BME, bone marrow oedema; CE, gadolinium contrast-enhancement; ERO, erosions; Inter, inter-reader reliability; JSN, joint space narrowing; 
MCP, metacarpophalangeal joint; MTP, metatarsophalangeal joint; RA, rheumatoid arthritis; SDD, smallest detectable difference; SYN, 
synovitis; T, Tesla; TS, tenosynovitis; intra, intrareader reliability (assessed by quadratic-weighted κ scores).
and CRP and with plantar plate pathology.18 19 22 When 
MRI-detected BME in MTP-joints was assessed histologi-
cally, it was associated with the severity of osteitis.19 One 
study found an association for BME with the develop-
ment of MRI-detected erosions a year later and reported 
that erosions were unlikely to develop in the absence 
of BME.20 Two studies did not find an association of 
BME with Disease Activity Score of 28 joints (DAS-28), 
Health Assessment Questionnaire (HAQ) or walking 
disability.15 21 Overall, four out of six studies found a 
positive association, therefore the evidence suggested 
construct validity to be present (‘++’).
Test-retest reliability has been investigated in one study 
that proved good inter-reader and intrareader reliability 
(‘+’).24 For the ability of MRI to discriminate in trials and 
for longitudinal construct validity, only studies of lower 
quality were available (‘+/-‘).5 26 There were no data on 
thresholds of meaning or feasibility (‘?’).
Tenosynovitis
Tenosynovitis is defined as tendon sheath fluid, sheath 
thickening and enhancement after intravenous contrast 
injection seen in two consecutive axial slices.13 Thus, for 
face and content validity, it is essential for the imaged 
tendon to have a sheath. The anatomy books that were 
consulted gave contradicting information. Regarding the 
extensor tendons some portrayed a sheath to be absent, 
but other anatomic atlases did not portray the extensor 
tendons at the MTP-region. At the flexor tendons of 
the MTP-joints some resources portrayed a sheath to 
be present, some did not or in some cases the region of 
interest was not depicted.27–30 Thus, it remains unclear 
whether a sheath is present around the tendons, and if so 
what its exact localisation is. This is relevant, as it questions 
the nature of the inflammation observed. Thus, face and 
content validity of tenosynovitis at the level of MTP-joints 
was absent (‘?’). In addition, no studies concerning teno-
synovitis at the MTP-joints have been performed to date 
(‘?’ for all OMERACT-elements).
erosions
MRI-detected bone erosions are defined as a sharply 
marginated bone lesion, with correct juxta-articular 
localisation and typical signal characteristics visible in 
two planes with a cortical break in at least one plane.2 
Face and content validity for erosions were assumed to 
be present (‘++’).
Five studies that met the criteria for the MRI-protocol 
were assessed for construct validity.15 16 20–22 MRI-detected 
erosions were associated with plantar plate pathology and 
with decreased movement of MTP-1.16 22 Also, MRI-de-
tected erosions were associated with the development 
of radiographic erosions 1 year later, and in the absence 
of MRI-detected erosions radiographic erosions were 
unlikely to occur.20 Two studies showed no correlation of 
MRI-detected erosions with DAS-28, HAQ or with walking 
disability.15 21 Overall, three out of five studies found a 
positive association, therefore the evidence suggested 
construct validity to be present (‘++’).
With regard to Discrimination, reliability was excellent 
in one study showing high inter-reader and intrareader 
reliability (‘+’).24 For longitudinal construct validity and 
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ability to discriminate, the found studies did not meet the 
criteria on the MRI-protocol (‘+/-’).5 25 26 Thresholds of 
meaning and feasibility have not been studied (‘?’).
Joint space narrowing
JSN is defined as reduced joint space width compared 
with normal, as assessed in a slice perpendicular to the 
joint surface.14 There is no reason to believe that face and 
content validity for JSN in the forefeet are not applicable 
(‘++’). As of yet, there are no studies on JSN in the fore-
feet in RA, therefore further validation is required (‘?’).
dIsCussIOn
This is the first SLR to assess the status of the develop-
ment or application of the RAMRIS for the feet. From 
the limited evidence available, a foot RAMRIS-score 
would be useful to evaluate the impact of inflammation 
and damage in the feet on long-term outcomes. Based on 
the results, as presented in table 4, construct validity is 
suggested for BME and erosions, but lacking for synovitis, 
tenosynovitis and JSN. Data for discrimination remain to 
be developed. A research agenda was formulated for the 
further evaluation of the validity of MRI of the forefoot, 
as presented in box 1.
In contrast to previous OMERACT Filters, Filter 2.1 
that was applied in this review does not distinguish 
between construct and criterion validity. Criterion validity 
assumes that the comparator instrument is a ‘gold stan-
dard’, for example, histology for MRI-detected BME.10 
In addition, previous studies have subdivided criterion 
validity further into concurrent validity and predictive 
validity, where concurrent validity assumed that the 
comparator instrument is a gold standard and predictive 
validity looked at a later status of, for example, a radio-
graphic or functional outcome.31 For the current study, 
all these different types of measures were taken together 
as ‘construct’. As a result, there were sufficient studies 
to conclude that construct validity was present BME and 
erosions. However, when one, for example, looks at only 
predictive validity, data are actually insufficient to draw 
conclusions on this aspect, as only one of the nine studies 
included in construct looked at the predictive value.20 
This was taken into consideration when formulating the 
research agenda. Determining the possible added value 
of MRI of the MTP-joints to that of MRI of the wrist and 
MCPs, and assessing the value of MRI of MTP-1 are also 
subjects for future research.
When studying the predictive accuracy of forefoot MRI 
in future studies, it might be relevant to include data 
from healthy controls in the definition of disease-related 
MRI-features. Previous studies demonstrated that inclu-
sion of information obtained from symptom-free persons 
from the general population increased the specificity and 
accuracy of MRI and that this finding also applies to the 
use of MRI of the MTP-joints.32 33
An updated version of the RAMRIS was recently 
published that now includes a definition of JSN and 
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Table 4 Validity of MRI measures of the forefeet in their assessment of inflammation and structural damage in RA
A: Presence of type of validity given for every MRI-measure
Type of validity Inflammation Structural damage
SYN BME TS ERO JSN
Truth
Face ++ ++ ? ++ ++
Content ++ ++ ? ++ ++
Construct +/– ++ ? ++ ?
Discrimination
Test-retest reliability + + ? + ?
Longitudinal construct validity +/– +/– ? +/– ?
Clinical Trial Discrimination +/– +/– ? +/– ?
Thresholds of meaning ? ? ? ? ?
Feasibility ? ? ? ? ?
B: Criteria handled for the interpretation of data
Category Definition Criteria for conclusion
++ Validity suggested for a positive association between 
MRI-measure and outcome
≥2 studies, ≥2/3rd have a uniform conclusion, and all 
of the following:
 ► MRI≥1.5 T
 ► CE for SYN and TS
+ Validity possibly suggested for a positive association 
between MRI-measure and outcome
One study with a positive association, and all of the 
following:
 ► MRI≥1.5 T
 ► CE for SYN and TS
+/– Insufficient data for a conclusion Studies are available, but one of the following:
 ► No uniform conclusion
 ► MRI on <1.5 T
 ► No CE for SYN and TS
– Validity possibly suggested for a negative association 
between MRI-measure and outcome
one study with a negative association, and all of the 
following:
 ► MRI≥1.5 T
 ► CE for SYN and TS
- - Validity suggested for a negative association between 
MRI-measure and outcome
≥2 studies,≥2/3rd have a uniform conclusion, and all of 
the following:
 ► MRI≥1.5T
 ► CE for SYN and TS
? No data available No studies available
*Uniform conclusion: studies pointing in the same direction (either positive or negative) with regard to the association for the MRI-
measurement with the outcome.
BME, bone marrow oedema; CE, gadolinium contrast-enhancement; ERO, erosions; JSN, joint space narrowing; SYN, synovitis; T, Tesla; TS, 
tenosynovitis.
tenosynovitis to previous versions in addition to the 
previous version that only included BME, synovitis and 
erosions. For tenosynovitis the updated RAMRIS shows 
subtle differences compared with the score developed by 
Haavardsholm et al that is generally used in MRI of wrist 
and MCPs.9 13 No validity data on the updated RAMRIS 
are published to date. However, as the definition of syno-
vitis, BME and erosions did not change, it is assumed 
that the observed results are also valid for the updated 
RAMRIS. No conclusions on the validity of tenosynovitis 
and JSN in the forefeet according to the older definitions 
or according to the updated RAMRIS could be drawn as 
there were no data available. Besides adding tenosyno-
vitis and JSN, the updated RAMRIS also included novel 
recommendations on the scan-protocol, such as a slice 
thickness of ≤2 mm in high-quality MRI units. However, 
it also states that the recommendations are not intended 
to be exclusive, but rather to provide common standards. 
In this review, the quality of the MRI-protocol was only 
weighted regarding field strength and CE, more thor-
ough details such as slice thickness and plane of scanning 
were not included in the evaluation.
The 13 included studies were heterogeneous in various 
aspects, such as the scan-protocols that were used and 
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box 1 Research agenda for the further validation of MRI 
of the forefeet
 ► evaluate whether Mri of the metatarsophalangeal (MtP)-joints 
performs better than Mri of the metacarpophalangeals (McPs) and 
wrists in predicting radiographic and/or functional outcomes, and if 
it could be used solely.
 ► Study whether Mri of the MtP-joints has additional value to Mri 
of the McPs and wrists in predicting radiographic and/or functional 
outcomes.
 ► assessing the value of Mri of MtP-1.
 ► Determine the longitudinal construct validity, clinical trial discrimi-
nation and thresholds of meaning for all Mri measures.
 ► evaluate the feasibility for all Mri measures.
 ► assess the anatomy of sheaths of tendons adjacent to MtP-joints 
for face and content validity.
 ► assess the association with clinical parameters for tenosynovitis 
and joint space narrowing for construct validity.
 ► assess the predictive value of all Mri features with radiographic 
and/or functional outcomes.
 ► assess the test-retest reliability of tenosynovitis and joint space 
narrowing and replicate this for synovitis, bone marrow oedema 
and erosions.
 ► assessment of validity in early rheumatoid arthritis (ra) versus es-
tablished ra.
the type of patients with RA that were included (early 
vs established RA). Most studies mention the use of a 
coil, varying from dedicated extremity coils19 to knee or 
wrist coils.17 While most studies scanned all MTP-joints, 
some made a selection.16 20 22 Not all studies used CE, 
potentially decreasing the reliability of synovitis scores.34 
Different field strengths were used, with a wide range of 
0.2–3 T, of which 1.5 T was most common. Lower field 
MRI<1.5 T generates lower imaging quality, which may 
influence the interpretability of the data. Therefore, for 
the final conclusions of this study, included studies were 
weighted depending on the use of CE for synovitis, an 
MRI field strength of ≥1.5 T and the presence of replica-
tion studies. The importance of the presence of replica-
tion studies is underlined by the small number of patients 
included in the studies. Although these weighing criteria 
(summarised in table 4) are arbitrary, they served to give 
a more critical appraisal of the data and enhance the 
interpretability of the results. Future studies should focus 
on ACR core set measures for their outcomes to make 
comparison of studies more attainable. Finally, studies 
showing a negative correlation could potentially have 
remained unpublished leading to a reporting bias that 
may have affected the results of this review.
In conclusion, although for synovitis, tenosynovitis 
and JSN data were lacking, for MRI-detected BME 
and erosions, truth of the RAMRIS of the forefeet was 
suggested by the data. In contrast, studies on discrimina-
tion and on feasibility are needed or require validation. 
Thus, the validity of applying the RAMRIS to the forefeet 
still is insufficient on different aspects. Awareness of the 
gaps in the OMERACT Filter criteria prior to including 
MRI of the MTP-joints in the RAMRIS and its implemen-
tation in trials is essential for optimal interpretation of 
results obtained.
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